CyberKnife Liver Cancer Treatment Overview

While advanced liver cancer patients may not be candidates for stereotactic body radiation therapy (SBRT), patients with early stage liver cancer or metastatic liver tumors may consider SBRT when seeking a treatment that allows them to maintain their daily routines and minimizes impact on a patient’€™s normal routine during and after treatment. In these cases, CyberKnife can benefit a liver cancer patient in a number of ways:

  • Accuracy: CyberKnife’€™s ability to treat tumors with precisely focused radiation may be an important advantage for liver cancer patients. Accurate to within less than a millimeter, SBRT delivered by CyberKnife minimizes radiation exposure to surrounding health tissue.
  • Duration of treatment: With conventional therapy, radiation is delivered in relatively small doses over several weeks. With SBRT, a greater combined dose of radiation is delivered within five or fewer sessions.
  • Noninvasive: The treatment is an outpatient, nonsurgical procedure that does not require anesthesia.
  • No recovery time: Patients experience few to no side effects and can return to their normal routine following each session.

When a liver cancer patient is referred to our center, our experienced team of multidisciplinary physicians reviews their case collaboratively. This approach offers patients a well-rounded and personalized treatment plan developed by doctors from various specialties.

CyberKnife Center of Chicago offers stereotactic body radiation therapy for liver tumors using CyberKnife® technology. View our treatment overview here.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.